LOCAL PROVIDER DIRECTORY
Find a dentist
Search by name or specialty, then choose a city and region or enter a ZIP / postal code.
Choose a location to keep your results local.
Local Health Alerts
Ransomware in U.S. Hospitals: What Recent Cyberattacks Mean for Patient Safety and Your Medical Records
Federal breach data show ransomware continues to disrupt U.S. hospitals, affecting patient care and exposing medical records. Here’s what that means for your health, privacy, and what you can do if your data are compromised.
Lung Cancer Screening in 2026: Who Should Get a Low-Dose CT and How It Prevents Advanced Disease
If you’re 50 to 80 and have a significant smoking history, you may qualify for annual low-dose CT lung cancer screening. Here’s what the evidence shows, who is eligible, what the trade-offs are, and how insurance coverage works in 2026.
Chiropractic Spinal Manipulation for Chronic Low Back Pain: What the Best Evidence Says in 2026
A major Cochrane review finds that spinal manipulation offers modest relief for chronic low back pain—about similar to exercise and other recommended non-drug treatments. Here’s what that means for patients, safety, Medicare coverage, and when to seek urgent care.
Colorectal Cancer Screening in 2026: Who Should Get Tested, Which Options Are Covered, and What the Latest Guidance Means for You
Colorectal cancer screening now starts at age 45 for most adults. Here’s what current U.S. guidelines say, how stool tests compare with colonoscopy, what happens after a positive result, and what insurance and Medicare typically cover.
Anti-Amyloid Alzheimer’s Drugs in 2026: Who Qualifies, What They Do, and What Families Should Know
FDA-approved anti-amyloid drugs like lecanemab can modestly slow early Alzheimer’s disease—but they are not cures. Here’s who qualifies, what the clinical trials showed, the real risks, and how Medicare coverage works in 2026.
Osteoporosis Screening in 2026: Who Should Get a Bone Density Test and Why It Matters
Most women 65 and older should be screened for osteoporosis, even if they feel fine. Here’s what the current U.S. Preventive Services Task Force recommendation says, what a DXA scan measures, and how insurance coverage works.
USPSTF Finalizes New Iron Deficiency Anemia Screening Guidance: What It Means for Infants, Pregnant People, and Adults
The U.S. Preventive Services Task Force has updated its guidance on screening for iron deficiency anemia. Here’s what the new grades mean for infants, pregnant people, and adults—and how they affect preventive care coverage under federal law.
Blood in the Urine: When Is It a Bladder Warning Sign?
Blood in the urine—whether you can see it or not—should never be ignored. Here’s what hematuria can mean, when it may signal bladder cancer, how doctors evaluate it, and when to seek urgent care.
What the 2025–2026 Respiratory Virus Season Means for People With Asthma
If you have asthma, federal health officials consider you at higher risk for complications from flu and COVID-19, and some groups face higher RSV risk. Here’s what the 2025–2026 respiratory virus season means for vaccines, action plans, and when to seek care.
When Insurers Use AI to Deny Care: What New Federal Rules and Investigations Mean for Patients
Medicare Advantage plans and other insurers increasingly use algorithms to review prior authorization and claims. Federal watchdog findings and new CMS rules clarify what’s allowed, what isn’t, and what rights patients have when care is denied.
How the FDA Regulates Artificial Intelligence in Healthcare — and What It Means for Patients in 2026
AI tools are increasingly used in U.S. hospitals and clinics, but not all of them are regulated the same way. Here’s how the FDA oversees AI-enabled medical devices, what clearance really means, and what patients should ask when AI is involved in their…
Biosimilars for Arthritis: What New U.S. Policy and Market Changes Mean for Patients in 2026
A surge of FDA-approved biosimilars for adalimumab and a redesigned Medicare Part D benefit with a $2,000 annual out-of-pocket cap are reshaping how Americans with arthritis pay for biologic drugs in 2026. Here’s what that means for your costs, coverage, and care decisions.
